Long-Term Satisfaction and Predictors of Use of Intracorporeal Injections for Post-Prostatectomy Erectile Dysfunction

被引:19
作者
Prabhu, Vinay [1 ]
Alukal, Joseph P. [1 ]
Laze, Juliana [1 ]
Makarov, Danil V. [1 ,2 ,3 ,4 ]
Lepor, Herbert [1 ,4 ]
机构
[1] NYU, Sch Med, Dept Urol, New York, NY 10016 USA
[2] NYU, Wagner Sch Publ Serv, New York, NY 10016 USA
[3] US Dept Vet Affairs Harbor Healthcare Syst, New York, NY USA
[4] NYU, Inst Canc, New York, NY 10016 USA
基金
美国国家卫生研究院;
关键词
prostate; prostatectomy; injections; erectile dysfunction; postoperative complications; QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; SELF-INJECTION; INTRACAVERNOSAL INJECTION; FOLLOW-UP; DROP-OUT; THERAPY; IMPOTENCE; CANCER; EXPERIENCE;
D O I
10.1016/j.juro.2012.08.089
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Intracorporeal injections have low use rates and high discontinuation rates. We examined factors associated with intracorporeal injection use, long-term satisfaction with intracorporeal injection and reasons for discontinuation in men treated with radical prostatectomy. Materials and Methods: Between October 2000 and September 2003, 731 men who underwent open radical retropubic prostatectomy were enrolled in a prospective outcomes study. The 8-year followup evaluation included the UCLA-PCI, and a survey capturing intracorporeal injection use, satisfaction and reasons for discontinuation. Logistic regression was used to determine associations between intracorporeal injection use and preoperative variables. Results: The 8-year self-assessment was completed by 368 (50.4%) men. Of these men 140 (38%) indicated prior or current intracorporeal injection use, with only 34 using intracorporeal injection at 8 years. Overall, 44% of the men were satisfied with intracorporeal injections. Reasons for discontinuation included dislike (47%), pain (33%), return of erection (19%), inefficacy (14%) and no partner (6%). Men trying intracorporeal injections had greater preoperative UCLA-PCI sexual function scores (75.2 vs 65.62, p = 0.00005) as well as greater decreases in this score at 3 months (p = 0.0002) and 2 years (p = 0.003). Higher preoperative sexual function scores were independently associated with the use of intracorporeal injections in a model adjusted for age, marital status, nerve sparing status and body mass index (OR 1.021, 95% CI 1.008-1.035). Conclusions: Men pursuing intracorporeal injections have better baseline erectile function and experience greater deterioration in erectile function during the early postoperative period. Despite the high efficacy of injections, many men discontinue intracorporeal injections due to dislike or discomfort. Satisfaction rates for intracorporeal injections indicate their long-term role in restoring sexual function in men with post-prostatectomy erectile dysfunction.
引用
收藏
页码:238 / 242
页数:5
相关论文
共 29 条
[1]   Prediction of Erectile Function Following Treatment for Prostate Cancer [J].
Alemozaffar, Mehrdad ;
Regan, Meredith M. ;
Cooperberg, Matthew R. ;
Wei, John T. ;
Michalski, Jeff M. ;
Sandler, Howard M. ;
Hembroff, Larry ;
Sadetsky, Natalia ;
Saigal, Christopher S. ;
Litwin, Mark S. ;
Klein, Eric ;
Kibel, Adam S. ;
Hamstra, Daniel A. ;
Pisters, Louis L. ;
Kuban, Deborah A. ;
Kaplan, Irving D. ;
Wood, David P. ;
Ciezki, Jay ;
Dunn, Rodney L. ;
Carroll, Peter R. ;
Sanda, Martin G. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (11) :1205-1214
[2]  
ALTHOF SE, 1989, J SEX MARITAL THER, V15, P121
[3]   Patient-reported quality of life after radical prostatectomy for prostate cancer [J].
Arai, Y ;
Okubo, K ;
Aoki, Y ;
Maekawa, S ;
Okada, T ;
Maeda, H ;
Ogawa, O ;
Kato, T .
INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (02) :78-86
[4]   Drop-out reasons and complications in self-injection therapy with a triple vasoactive drug mixture in sexual erectile dysfunction [J].
Casabe, A ;
Bechara, A ;
Cheliz, G ;
Romano, S ;
Rey, H ;
Fredotovich, N .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 1998, 10 (01) :5-9
[5]  
Claro J de A, 2001, Sao Paulo Med J, V119, P135
[6]   Reasons of dropout from short- and long-term self-injection therapy for impotence [J].
de la Taille, A ;
Delmas, V ;
Amar, E ;
Boccon-Gibod, L .
EUROPEAN UROLOGY, 1999, 35 (04) :312-317
[7]   Clinical Outcomes of Intracavernosal Injection in Postprostatectomy Patients: A Single-center Experience [J].
Domes, Trustin ;
Chung, Eric ;
Ling DeYoung ;
MacLean, Natalie ;
Al-Shaiji, Tariq ;
Brock, Gerald .
UROLOGY, 2012, 79 (01) :150-155
[8]  
FALLON B, 1995, UROL CLIN N AM, V22, P833
[9]   Long-term follow-up of patients with erectile dysfunction commenced on self injection with intracavernosal papaverine with or without phentolamine [J].
Flynn, RJ ;
Williams, G .
BRITISH JOURNAL OF UROLOGY, 1996, 78 (04) :628-631
[10]   Changes in Continence and Erectile Function Between 2 and 4 Years After Radical Prostatectomy [J].
Glickman, Leonard ;
Godoy, Guilherme ;
Lepor, Herbert .
JOURNAL OF UROLOGY, 2009, 181 (02) :731-735